checkAd
    Startseite > Aktien > Arbutus Biopharma > Nachrichten
    Arbutus Biopharma Aktie
    2,6780
     
    EUR
    -0,67 %
    -0,0180 EUR
    Letzter Kurs 10.05.24 Tradegate
    2,6480
     
    EUR
    755 STK
    Geldkurs 10.05.24
    2,7080
     
    EUR
    738 STK
    Briefkurs 10.05.24
    ISIN: CA03879J1003 · WKN: A14XMD · SYM: I9DN · Kanada

    Neueste Nachrichten

    Arbutus to Participate in Two Upcoming Investor Conferences
    07.05.24 · globenewswire · Arbutus Biopharma
    Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
    02.05.24 · globenewswire · Arbutus Biopharma
    Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
    02.05.24 · globenewswire · Arbutus Biopharma
    Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
    18.04.24 · globenewswire · Arbutus Biopharma
    Die größten Aufsteiger der Woche vom 03.04.-10.04.2024 in der wO Community
    10.04.24 · wO Chartvergleich · Bayer
    Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
    04.04.24 · globenewswire · Arbutus Biopharma
    Arbutus to Participate in Two Upcoming Investor Conferences
    08.03.24 · globenewswire · Arbutus Biopharma
    Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
    29.02.24 · globenewswire · Arbutus Biopharma
    Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
    15.02.24 · globenewswire · Arbutus Biopharma
    Die größten Aufsteiger der Woche vom 07.02.-14.02.2024 in der wO Community
    14.02.24 · wO Chartvergleich · Gabriel Resources
    Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
    08.01.24 · globenewswire · Arbutus Biopharma
    Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting
    09.11.23 · globenewswire · Arbutus Biopharma